Investor Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 410 - (OTC: $SKDI) (CSE: $NLB.C) (OTC: $PHCG) (CSE: $IMCC.C) (TSXV: $NRTH.V) (TSX: $AVCN.TO)
Today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: $CSUI)
Delta, Kelowna, BC, May 7, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI), a research & development company licensed under Swiss Cannabis and tobacco regulations to cultivate and sell cannabis. The Company's facilities for producing cannabis are based in Zurich.
The Company grows high quality, organic cannabis with sustainable, all-natural principles. Cannabis Suisse products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product.
In today’s podcast we will be looking at a few public and private company announcements.
Sun Kissed Industries Inc. (OTC: SKDI), an emerging leader in the CBD Food and Beverage marketplace, subsidiary Products Group Inc, DBA/ Hakuna Supply announced that April online sales far surpassed the anticipated numbers.
Hakuna's retail store clientele have increased their orders ahead of the cross country 're-opening', causing a backlog of thousands of CBD Biometric Sensor Storage Devices along with multiple orders across all product lines.
A new affiliate marketing program for Hakuna has been developed with an initial goal of 10-15 on boarded marketers per month. This program rewards marketers for their efforts in increasing Hakuna's client base. Please visit Hakuna's website for an application and full program details: https://hakunasupplycbd.com/affiliate-application/
In 2018, content marketing costs were gauged to be 62% of traditional marketing schemes while simultaneously generating three times the leads of traditional methods. According to Bigcommerce.com, the US affiliate market will surpass $6.8 billion this year.
"The new clean room is facilitating the fulfillment of increased online and traditional brick-and-mortar store orders. During the past month we have put the finishing touches on our affiliate market program launching this month. Our new combined marketing could result in over $750,000 in new sales this year," commented Hakuna CEO, Ilan Freeman. "Plans for festivals, typically during the end of summer and early fall seasons, are further bolstering sales."
"Our team at Sun Kissed is working closely with Hakuna to increase inventory and the number of festivals attended this year. We couldn't be happier with the results coming in for Q1 and Q2 as well as the outlook for the rest of 2020" concluded Carl Grant, CEO of Sun Kissed.
NewLeaf Brands Inc. (CSE: NLB) (OTC: NLBIF) announced that it has signed a definitive agreement dated May 5, 2020 with Trellis Holdings Oregon, LLC. to acquire 37.5% of the issued and outstanding share capital of Trellis Holdings Oregon Op LLC from David Joshua Bartch and Benjamin Martch by way of a share exchange, as previously announced on February 6th, 2020.
Trellis Holdings Oregon, LLC has been successfully operated since 2015 by a group of cannabis industry veterans and cultivates thousands of pounds of high-quality cannabis per year, including strains that exceed 30% in THC content, and has 7 figure revenues that continue to grow significantly year over year. Trellis holds various licenses with the OLCC in the state of Oregon and operates in both the medical and recreational cannabis markets, maintaining an 11-acre recreational cultivation property in Southern Oregon and operating a medical and recreational cannabis dispensary in Portland, Oregon.
"We announced the LOI to acquire a position in Trellis some time back and have been working diligently to close the transaction," commented Joshua Bartch, CEO of NewLeaf Brands. "This transaction is significant in a number of ways for the company. Not only does Trellis bring a wealth of assets, potential revenue and key personnel but the crossover between the cannabis space and the mycology space is immense."
Mr. Bartch continued, "Through Initiative #34, Oregon is poised to be the first territory on the planet to not just decriminalize, but actually legalize, psychedelic mushrooms in some capacity. Given that Trellis operates its cultivation in Sothern Oregon on an 11-acre property that is already owned, debt-free, by NewLeaf Brands, the Company has a unique opportunity to share the land and staff for a potential future mycology cultivation space and laboratory." He concluded, "With recent donations to the tune of $1,000,000 towards the Petition from prominent companies such as Dr. Bronner's Soap, the likelihood of the initiative becoming a reality is beginning to look truly promising."
According to the campaign for the initiative, "IP 34 gives those suffering from depression, anxiety, and anyone that would benefit, a new treatment option by creating a licensed and supervised psilocybin-assisted therapy system. Rigorous studies at leading medical research institutions such as Johns Hopkins, UCLA, and NYU show that psilocybin therapy is uniquely effective in treating depression, anxiety, and addiction. This promising research has prompted experts in Oregon to advance IP 34 for the November ballot — IP 34 will create a licensed psilocybin therapy program so Oregonians have the best therapeutic options available."
Pure Harvest Cannabis Group, Inc. (OTC: PHCG), an emerging cannabis and hemp-CBD holding company, announced the official launch of its wholly owned subsidiary, Wild Pet Blends, a CBD-based pet supplement company.
Wild Pet Blends offers unique full-spectrum hemp extract products that go beyond what is currently offered in the CBD market for pets. It’s scientifically curated blends have been designed as multi-dimensional pet supplements and chews that combine vitality enhancing full spectrum CBD, anti-oxidants, essential fats, vitamins, and minerals in combination with digestive enzymes and probiotics for your pet’s overall health and wellness.
Wild Pet Blends has an aggressive development plan that includes top-tier sales talent with over 25 years in the pet industry, distribution partnerships, and expanded product offerings. The Company’s ability to produce a steady supply of premium Full-Spectrum hemp oil that is rich in cannabinoids will be a key differentiating factor for our product line.
“We continue to diversify our portfolio of holdings in the cannabis space,” stated Matt Gregarek, CEO, Pure Harvest Cannabis Group. “Our objective is to develop, identify, and acquire operations in the fastest growing sectors of the already rapidly growing cannabis industry and to establish durable revenue lines. The expansion of the CBD pet market is clear and Wild Pet Blends offers a tremendous catalog of superior products.”
IM Cannabis Corp. (CSE:IMCC), one of the world's pioneering medical cannabis companies with operations in Israel and across Europe, announced that its German subsidiary, Adjupharm GmbH, has obtained definitive purchase commitments for 360kg of medical cannabis over the next twelve months with two distributors in Germany. Adjupharm is fully licensed for the import, export and distribution of medical cannabis products in Germany.
Oren Shuster, Chief Executive Officer of IMC commented, "Over the past year, we have taken the steps required to enter the German market and scale quickly, backed by a 10-year track record of successful operations in Israel. Germany is the third largest medical cannabis market in the world and continues to present a large opportunity for focused operators like IMC. The commitments obtained today are a significant achievement in the roll-out of IMC's strategy in Germany and they are pivotal to growing brand awareness, with a view to increasing our international penetration as well as preparing to enter other attractive countries in the EU. IMC is experienced at building productive relationships within the retail pharmacy channel and have already formed partnerships with trusted cultivators for product fulfillment. With $193.5 million in revenue and expected gross margins of 50% secured through binding agreements over the past two months in Israel and now purchase commitments in Europe's largest market, we have made meaningful strides towards our long-term success. Our strategy will continue to unfold in the coming months as we expand our network of partnerships to maximize the distribution of IMC-branded products in Germany."
Through its EU-GMP certified subsidiary, Adjupharm, the Company has entered into two binding three-to-twelve month sales agreements with two pharmaceutical distributors in Germany. Each of the distributors has entered into individual purchase commitments under the respective sales agreements. The total quantity of medical cannabis under the Purchase Commitments is 360kg, with 340kg expected to be delivered in 2020.
The first shipment to distributors in Germany is expected in June 2020. Medical cannabis sold under these Purchase Commitments will be fulfilled primarily from the Company's EU-GMP certified supply partner in Europe.
The Purchase Commitments are the Company's first binding contracts for the sale of medical cannabis in Germany under the IMC brand. IMC has also previously announced that Focus Medical Herbs Ltd. has signed six binding sales agreements for the distribution of IMC-branded medical cannabis products in Israel. Total consolidated revenue from all binding sales agreements in Israel is expected to be $193.5 million with an expected gross margin of 50%. A total of 33,075kg of medical cannabis will be delivered in Israel between Q2 2020 and 2023, and 3,000kg of medical cannabis under the sales agreements is expected to reach pharmacies in 2020.
48North Cannabis Corp. (TSXV:NRTH), announced that it has signed a key supply agreement with Medical Cannabis by Shoppers Drug Mart Inc., a subsidiary of Shoppers Drug Mart Inc.
Under the terms of the agreement, 48North will become a supplier of cannabis and cannabis products through the Shoppers online sales platform. As a result, 48North-branded products and licensed brands will now be available to Medical Cannabis by Shoppers™ patients across Canada.
To begin, the Company will be introducing Apothecanna by 48North, an established U.S cannabis brand focused on natural topical formulations, made without the use of artificial ingredients, fillers, parabens, or GMO ingredients. Apothecanna has been a leading topicals brand in the United States since its founding in 2009.
"Partnering with trusted brands like Medical Cannabis by Shoppers has been a cornerstone of 48North's growth plan since the beginning. The Company continues to sign agreements and build meaningful partnerships with a collection of the most beloved and trusted brands in Canada. Today's news, announced on the heels of the Company's agreements with Indigo and Pax, continues to build on 48North's momentum," said Charles Vennat, CEO of 48North.
"48North can now truly say that its brand and products are available across the country. We could not be prouder to partner with one of the most respected brands in Canadian retail, we look forward to bringing our high-quality, consistent and natural product offerings to medical cannabis patients," continued Charles.
Successfully signing a supply agreement with Shoppers is indicative of 48North's renewed commitment to improving operations, investing in product development, and supporting high-quality experiences for Canadian consumers.
48North applauds the hard work that Shoppers has done to ensure that all Canadians have access to quality products as well as trusted guidance from their specialized medical cannabis advisors.
Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, announced that, through its cultivation subsidiary Santa Marta Golden Hemp S.A.S., it has received the approval from the Colombian government for the industrial export of hemp seeds to the US.
The export, which is expected to be completed in the next two weeks, is the first ever export of cannabis seeds from Colombia and will be accomplished thanks to the support and coordination of the Colombian Institute of Agriculture, and the Ministries of Agriculture and Justice for Colombia.
"For the Colombian government, under the leadership of the Ministry of Justice and Law and during the COVID-19 sanitary emergency, this is a very important achievement for the medical cannabis industry" said Dumar Cardenas Poveda, Subdirector of Control and Inspection of Narcotic Drugs and Chemical Substances of the Ministry of Justice and Law.
"This is a very important achievement because it can mark the way for an escalation of future exports in this industry. The ICA, considering the framework of Decree 613 of 2017, has given the technical support and reviewed the necessary information to materialize this first exportation. We are opening these new opportunities for this industry, in which there is a significant business expectation" said Deyanira Barrero León, Director General of the Colombian Institute of Agriculture.
"The cannabis industry in Colombia, being a nascent sector, has faced great challenges of establishing its pathways and standardizing its regulatory processes. For this reason, in the particular case of this export, the advice of ICA and the support of the Ministries of Agriculture and Justice have been pivotal factors in allowing us to harvest in the times demanded by the client in the United States." said Lucas Nosiglia, President of Avicanna's Latin American operations.
Mr. Nosiglia explained that rather than a single company milestone, this is an achievement for the whole cannabis industry in Colombia as it also adds a novel and less visited business market opportunity of genetics and seeds to the global markets. Mr. Nosiglia emphasized
"This export is the faithful proof that the cannabis sector is in a position to support the socio-economic revival that the country requires in the midst of the COVID-19 pandemic. Medical cannabis attracts foreign investment, generates employment, increases the nation's tax revenues, expands the export matrix and contributes to the development of rural areas."
Once again, today’s podcast was sponsored by Cannabis Suisse Corp. (OTC: CSUI), a research & development company licensed under Swiss Cannabis and tobacco regulations to cultivate and sell cannabis. The Company's facilities for producing cannabis are based in Zurich.
The Company grows high quality, organic cannabis with sustainable, all-natural principles. Cannabis Suisse products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: CSUI is a paid monthly featured cannabis company on Investor ideas. More disclaimer info:
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Contact Investorideas.com
800 665 0411
